Ingredion Incorporated

What they do

Ingredion processes corn, tapioca, potato, peas, and rice into starches, sweeteners, animal feed, edible corn oil, and pulse-based protein ingredients. It serves over 60 industries, primarily food and beverage, brewing, animal nutrition, and industrial applications. The company operates three reportable segments: Texture & Healthful Solutions (T&HS), Food & Industrial Ingredients LATAM (F&II LATAM), and Food & Industrial Ingredients U.S./Canada (F&II U.S./Canada), with All Other for remaining operations.

Revenue drivers

• Starches — Food-grade and industrial starches, biomaterials, and non-GMO products; represented 50% of net sales in 2025.
• Sweeteners — Glucose syrups, high fructose corn syrup, dextrose, polyols, and high-intensity sweeteners; represented 34% of net sales in 2025.
• Texture & Healthful Solutions (T&HS) — Fastest-growing segment, focused on clean-label and functional ingredients; reported ninth consecutive quarter of net sales volume growth in Q2 2026.
• Other products — Pulse-based proteins, corn oil, corn gluten feed/meal, and multi-ingredient systems; plus F&II LATAM and U.S./Canada segments contribute volumes.

Recent performance

In Q2 2026, net sales were $1.85 billion, up slightly from $1.83 billion in Q2 2025, but reported net income attributable to Ingredion fell to $114 million from $196 million, and diluted EPS dropped to $1.78 from $2.99. The decline was driven by restructuring/impairment charges ($45 million), acquisition integration costs, and lower operating income ($188 million vs. $271 million). Adjusted EPS was $2.82, down from $2.87. For full-year 2025, net sales were $7.22 billion, down 3% from 2024, while net income rose 13% to $729 million and diluted EPS was $11.18.

Strategy

Ingredion is executing a solutions-selling model, emphasizing clean-label and specialty ingredients, and optimizing its global network, including closing facilities (e.g., Cabo, Brazil) and divesting non-core assets (sold majority stake in Pakistan business). The company is pursuing the all-cash acquisition of Tate & Lyle (595 pence per share), which shareholders approved on July 28, 2026, to expand its global ingredient solutions footprint. Management is focused on improving reliability at the Argo plant, accelerating T&HS growth, and integrating Tate & Lyle operations.

Risks

• Consumer preferences shift — Increasing consumer avoidance of added sugars, sweeteners, and highly-processed foods could reduce demand for core products like high fructose corn syrup.
• Weight loss medication impact — Expanded use of weight loss drugs may reduce overall food and beverage consumption, lowering demand for Ingredion's ingredients.
• Commodity price volatility — Fluctuations in corn and competing crop prices (e.g., sugar, soybean) directly affect margins and pricing, as seen in 2025's lower corn costs pass-through.
• Integration and execution risk — The pending Tate & Lyle acquisition and network optimization (plant closures) carry execution, integration, and regulatory risks.

Outlook

Management reaffirmed amended full-year 2026 guidance reflecting the sale of the Pakistan business: reported EPS of $9.15-$9.75 and adjusted EPS of $10.30-$10.90. They expect continued operational execution across F&II businesses and accelerating T&HS growth, with the Tate & Lyle acquisition expected to close pending approvals. The company also anticipates completing integration planning and navigating foreign exchange headwinds and macroeconomic pressures.